US Stock MarketDetailed Quotes

FDMT 4D Molecular Therapeutics

Watchlist

4.800
+0.260+5.73%

Close Feb 26 16:00 ET

4.720
-0.080-1.67%

Post 20:01 ET

221.89MMarket Cap-1.68P/E (TTM)

4D Molecular Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

4D Molecular Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 176.000K	--
--	2024/Q4	-- / 2.284M	--
--	2024/Q3	3.000K / 601.140K	--
--	2024/Q2	5.000K / 685.710K	--
--	2024/Q1	28.000K / 915.710K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 176.000K--

--2024/Q4-- / 2.284M--

--2024/Q33.000K / 601.140K--

--2024/Q25.000K / 685.710K--

--2024/Q128.000K / 915.710K--

Unlock Free Earnings Estimates

Open Account

4D Molecular Therapeutics Earnings Reports

4D Molecular Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 16:34 ET

4D Molecular Therapeutics | 8-K: 4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones

Nov 13, 2024 16:23 ET

4D Molecular Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 16:24 ET

4D Molecular Therapeutics | 8-K: 4DMT Reports Second Quarter 2024 Financial Results and Operational Highlights

Aug 8, 2024 16:23 ET